Japan To Subsidize Development Of Cancer-Targeted Diagnostic Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan's health ministry has decided to subsidize research into developing diagnostic drugs for targeting specific cancer cells, according to sources.
Japan's health ministry has decided to subsidize research into developing diagnostic drugs for targeting specific cancer cells, according to sources. The plan calls for the Ministry of Health, Labor and Welfare to take applications from universities and drug-developing institutions and select those to receive subsidies as of fiscal year 2013. The ministry's intent of the support is to reduce waste, side effects and costs for patients by promoting use of drugs that target specific cells. (Click here for more - a subscription may be required
)
"Government To Subsidize Development Of Diagnostic Drugs" - Nikkei (Japan) (9/16/2012)